12/11/2025
Growth attracts growth, and adoption is driven by one thing: does a solution outperform what exists today?
At Locus FS, the answer has been a consistent yes. Our proprietary glycolipid biosurfactants & novel microbes are delivering superior performance in complex, real-world production environments — from energy and mining to agriculture and industrial & CPG.
Today, we announced a $40M strategic investment led by Hudson Bay Capital Management LP, with participation from the management team, to accelerate production, expand commercial deployment, and fast-track new high-performance formulations already in development.
This funding powers what the market has already validated: scalable, differentiated products that work under the most demanding industrial conditions.
We appreciate Hudson Bay Capital Management LP for leading this round and partnering with us in the next phase of growth.
Recent funding round, led by Hudson Bay Capital, fuels expanded capacity and commercialization of formulated intermediates across oil & gas, mining, agriculture and industrial & CPG markets SOLON, OH (November 2025) — Locus Fermentation Solutions (Locus FS), a U.S.-based biotechnology company prod...